Icon

LYMEPAK (nda209844)- (EQ 100MG BASE)

DOXYCYCLINE HYCLATE CHARTWELL PHARMA
EQ 100MG BASE
No Yes
Expired Expired
None None
None No
LYMEPAK is a tetracycline class drug indicated for the treatment of early Lyme disease (as evidenced by erythema migrans) due to Borrelia burgdorferi in adults and pediatric patients 8 years of age and older weighing 45 kg and above.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 100MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.